Cargando…
Multigene panel sequencing of established and candidate melanoma susceptibility genes in a large cohort of Dutch non‐CDKN2A/CDK4 melanoma families
Germline mutations in the major melanoma susceptibility gene CDKN2A explain genetic predisposition in only 10–40% of melanoma‐prone families. In our study we comprehensively characterized 488 melanoma cases from 451 non‐CDKN2A/CDK4 families for mutations in 30 established and candidate melanoma susc...
Autores principales: | Potjer, Thomas P., Bollen, Sander, Grimbergen, Anneliese J.E.M., van Doorn, Remco, Gruis, Nelleke A., van Asperen, Christi J., Hes, Frederik J., van der Stoep, Nienke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590189/ https://www.ncbi.nlm.nih.gov/pubmed/30414346 http://dx.doi.org/10.1002/ijc.31984 |
Ejemplares similares
-
Association between a 46-SNP Polygenic Risk Score and melanoma risk in Dutch patients with familial melanoma
por: Potjer, Thomas P, et al.
Publicado: (2021) -
Assessing a single SNP located at TERT/CLPTM1L multi-cancer risk region as a genetic modifier for risk of pancreatic cancer and melanoma in Dutch CDKN2A mutation carriers
por: Christodoulou, E., et al.
Publicado: (2019) -
Surveillance, CDKN2A and survival of familial melanoma
por: van Doorn, Remco
Publicado: (2023) -
Genome-wide analysis of constitutional DNA methylation in familial melanoma
por: Salgado, Catarina, et al.
Publicado: (2020) -
Genotype-phenotype correlations for pancreatic cancer risk in Dutch melanoma families with pathogenic CDKN2A variants
por: Overbeek, Kasper A, et al.
Publicado: (2021)